Codman Neuro has announced at the Live Interventional Neuroradiology and Neurosurgery Course (LINNC) in Paris, France, that it has obtained CE marking for the REVIVE SE, a self-expanding clot removal device for use in treating acute ischaemic stroke.
According to the company, the REVIVE SE device is a self-expanding nitinol basket that is designed to ease navigation through small and tortuous blood vessels and arteries in the cerebral vasculature, and enable rapid restoration of blood flow to the brain during an acute ischaemic stroke.
The device features a closed-ended soft distal tip to capture clots and large fragments with minimal trauma, and a narrow and tall strut design to better penetrate and engage more clot, it was stated in a company press release. The new strut design also lowers the force required to track the device through a 0.021 micro-catheter.
“Ease of navigation is extremely important during a procedure like thrombectomy in terms of safety and time savings,” said Martin Bendszus, Department of Neuroradiology, University of Heidelberg, Germany. “The new device offers good navigation, and based on procedures with its predecessor device, provides consistently good recanalisation rates and outcomes.”
CE marking for the first generation REVIVE SE device was obtained in February 2011. In addition to clot removal, according to the company, clinicians can use the REVIVE SE devices for the non-surgical removal of emboli and thrombi, with aspiration and with the injection or infusion of contrast media and other fluids. The devices are not currently approved for distribution in the USA.
“We are pleased to enhance our technology platform for ischaemic stroke in a way that improves the overall clinical experience,” said P Laxmin Laxminarain, worldwide president of Codman Neuro. “Clinicians told us enhanced navigation was important to them and we have responded with the next generation REVIVE SE.”
